COMP <GO>
COGT vs MANE // EV/EBITDA & P/E VALUATION
Cogent Biosciences Inc. (NASDAQ) VS. Veradermics Incorporated (NYSE) • 15-METRIC TALLY: COGT 3
— MANE 8
■ METRIC PARITY
LAST: $29.73 (-4.16%) • MKT CAP: $5.38B
valuation
—
LAST: $129.53 (-7.27%) • MKT CAP: $5.84B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (COGT VS. MANE)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | COGT | MANE | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -11.90% | -23.10 | MANE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -4.80% | -1.19% | -3.61 | MANE | /fcf-yield <GO> |
| Operating Margin | -21.50% | -4.30% | -17.20 | MANE | /operating-margins <GO> |
| Net Profit Margin | -21.20% | -4.20% | -17.00 | MANE | /net-margins <GO> |
| Revenue Growth (YoY) | 22.00% | 4.40% | +17.60 | COGT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 10.84 | 26.00 | -15.16 | MANE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 4/9 | +1.00 | COGT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.2 | 60.4 | -13.20 | MANE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.05 | 1.07 | -0.02 | MANE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 22.0x | 24.0x | -2.00 | COGT | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.38B | $5.84B | -$453.5M | MANE | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | COGT REV | MANE REV | COGT GROSS % | MANE GROSS % | COGT FCF | MANE FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $933.4M | $202.6M | — | — | -$266.0M | -$71.6M |
| FY 2024 | $772.6M | $75.0M | — | — | -$208.4M | -$23.7M |
| FY 2023 | $582.8M | — | — | — | -$153.6M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
COGT // BETA 1.05
MANE // BETA 1.07